Literature DB >> 11334433

Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays.

A K Cardozo1, M Kruhøffer, R Leeman, T Orntoft, D L Eizirik.   

Abstract

Type 1 diabetes is an autoimmune disease resulting from the selective destruction of insulin-producing beta-cells. Cytokines may contribute to pancreatic beta-cell death in type 1 diabetes. beta-cell exposure to interleukin (IL)-1beta induces functional impairment, whereas beta-cell culture for 6-9 days in the presence of IL-1beta and interferon (INF)-gamma leads to apoptosis. To clarify the mechanisms involved in these effects of cytokines, we studied the general pattern of cytokine-induced gene expression in beta-cells. Primary rat beta-cells were fluorescence-activated cell sorter-purified and exposed for 6 or 24 h to control condition, IL-1beta + INF-gamma, or IL-1beta alone (24 h only). Gene expression profile was analyzed in duplicate by oligonucleotide arrays. Nearly 3,000 transcripts were detected in controls and cytokine-treated beta-cells. Of these, 96 and 147 displayed changes in expression after 6 and 24 h, respectively, of exposure to IL-1beta + INF-gamma, whereas 105 transcripts were modified after a 24-h exposure to IL-1beta. The cytokine-responsive genes were clustered according to their biological functions. The major clusters observed were metabolism, signal transduction, transcription factors, protein synthesis/ processing, hormones, and related receptors. These modifications in gene expression may explain some of the cytokine effects in beta-cells, such as decreased protein biosynthesis and insulin release. In addition, there was induction of diverse cytokines and chemokines; this suggests that beta-cells may contribute to mononuclear cell homing during insulitis. Several of the cytokine-induced genes are potentially regulated by the transcription factor NF-kappaB. Clarification of the function of the identified cytokine-induced gene patterns may unveil some of the mechanisms involved in beta-cell damage and repair in type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334433     DOI: 10.2337/diabetes.50.5.909

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  77 in total

1.  Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells.

Authors:  K L A Souza; M Elsner; P C F Mathias; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2004-07-10       Impact factor: 10.122

2.  STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation.

Authors:  Fabrice Moore; Najib Naamane; Maikel L Colli; Thomas Bouckenooghe; Fernanda Ortis; Esteban N Gurzov; Mariana Igoillo-Esteve; Chantal Mathieu; Gianluca Bontempi; Thomas Thykjaer; Torben F Ørntoft; Decio L Eizirik
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

3.  Genome-wide identification of palmitate-regulated immediate early genes and target genes in pancreatic beta-cells reveals a central role of NF-κB.

Authors:  Hyung Jin Choi; Seungwoo Hwang; Se-Hee Lee; You Ri Lee; Jiyon Shin; Kyong Soo Park; Young Min Cho
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

Review 4.  Protein phosphatases in pancreatic islets.

Authors:  Henrik Ortsäter; Nina Grankvist; Richard E Honkanen; Åke Sjöholm
Journal:  J Endocrinol       Date:  2014-03-28       Impact factor: 4.286

5.  Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets.

Authors:  P Ylipaasto; B Kutlu; S Rasilainen; J Rasschaert; K Salmela; H Teerijoki; O Korsgren; R Lahesmaa; T Hovi; D L Eizirik; T Otonkoski; M Roivainen
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

Review 6.  Candidate genes expressed in human islets and their role in the pathogenesis of type 1 diabetes.

Authors:  Joachim Storling; Caroline Anna Brorsson
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

7.  Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways.

Authors:  A E Karlsen; P E Heding; H Frobøse; S G Rønn; M Kruhøffer; T F Orntoft; M Darville; D L Eizirik; F Pociot; J Nerup; T Mandrup-Poulsen; N Billestrup
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

8.  A combined "omics" approach identifies N-Myc interactor as a novel cytokine-induced regulator of IRE1 protein and c-Jun N-terminal kinase in pancreatic beta cells.

Authors:  Flora Brozzi; Sarah Gerlo; Fabio Arturo Grieco; Tarlliza Romanna Nardelli; Sam Lievens; Conny Gysemans; Lorella Marselli; Piero Marchetti; Chantal Mathieu; Jan Tavernier; Décio L Eizirik
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

9.  Contrasting patterns of expression of transcription factors in pancreatic alpha and beta cells.

Authors:  Jie Wang; Gene Webb; Yun Cao; Donald F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

10.  Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes.

Authors:  Noemí Alejandra Saavedra-Ávila; Upasana Sengupta; Begoña Sánchez; Ester Sala; Laura Haba; Thomas Stratmann; Joan Verdaguer; Dídac Mauricio; Belén Mezquita; Ana Belén Ropero; Ángel Nadal; Conchi Mora
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.